We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

R-Biopharm to Use SCIENIONs sciFLEXARRAYER for the Production of Novel Chips Designed to Detect Antibiotics in Milk

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

SCIENION AG has announced that R-Biopharm AG - a leading developer of products for clinical diagnostics and food & feed analysis- will use SCIENION’s sciFLEXARRAYER technology to produce innovative chips for the detection of antibiotic residues in milk.

“We have a novel chip in our product portfolio in the business segment food analysis to simultaneously detect residues of different antibiotics in milk qualitatively and quantitatively very quickly. This represents an innovation for consumer safety and for the milk processing industry”, stated Dr. Peter Schubert, Head Research and Development at R-Biopharm AG.

Dr. Schubert “For the reproducible high throughput production of this chip in top quality we have been looking for the best available devices for lab automation and production. Tests have shown that the sciFLEXARRAYER clearly achieved the best results compared to other devices. Therefore, we decided for the SCIENION technology.”

The innovative “milkchip” hast two major applications. On one hand it is dedicated to a better consumer protection in order to avoid any health risks caused by antibiotic residues in milk. On the other hand antibiotics in milk are also a problem for the milk processing industry.

Antibiotics inhibit the growth of bacteria and thus also of lactic acid bacteria and other cultures essential for the production of yoghurt, cheese and other milk products. A test before processing the milk is useful to avoid such problems.

Dr. Holger Eickhoff, CEO of SCIENION AG, commented: “We are very pleased that R-Biopharm has decided for our sciFLEXARRAYER and we thus demonstrate once more the broad spectrum of applications of our technology. It is our strength to enable precise dispensing of any content in the pico- and nanoliter range and this is increasingly required in the areas of screening, analytics and diagnostics.”

Ahmed AitBenarrou, head of the microarray group at R- Biopharm, added: “A unique feature of our chip is furthermore that the chip is regenerative. This means you can -after appropriate washing procedures - analyze about 100 milk samples with a single chip - a clear advantage for our customers." The launch of the "milkchip” is planned for midyear 2012.